Clinical trial reportClinical lung cancerPublished
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
15 of 32 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- Counties
- Chester County, Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Clinical lung cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Disease Progression; Acrylamides; Aniline Compounds; Pyrimidines; Indoles; Antineoplastic Combined Chemotherapy Protocols; Mutation; Quality of Life; Aged
- PubMed ID
- 41544603
- Added to directory
- Source checked